IONIS PHARMACEUTICALS INC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Carlsbad, CA
SEC filing record 1 source field available
Fiscal year end
31 December
IONIS PHARMACEUTICALS INC has filed 2,658 SEC EDGAR filings since 12 Jun 1996

SEC filing history

Showing 751-775 of 1,000 matching filings.

Per page
25
Current page
31
4

PRIMARY DOCUMENT

Filing date
06 Jul 2022
Reporting date
01 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Jun 2022
Reporting date
10 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
09 Jun 2022
Reporting date
07 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-19125

IONIS PHARMACEUTICALS INC 10-Q 3-31-2022

Filing date
04 May 2022
Reporting date
31 Mar 2022
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
25 Apr 2022
Reporting date
21 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 000-19125

DEFA14A

Filing date
20 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-19125

DEF 14A

Filing date
20 Apr 2022
Reporting date
02 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Apr 2022
Reporting date
18 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Apr 2022
Reporting date
15 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Apr 2022
Reporting date
12 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-41771

SC 13G/A filing

Filing date
11 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Apr 2022
Reporting date
01 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Mar 2022
Reporting date
28 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Mar 2022
Reporting date
28 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Mar 2022
Reporting date
28 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Mar 2022
Reporting date
28 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Mar 2022
Reporting date
28 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Mar 2022
Reporting date
28 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-19125

IONIS PHARMACEUTICALS, INC. 10-K 12-31-2021

Filing date
25 Feb 2022
Reporting date
31 Dec 2021
Next action
Verify source filing
5

PRIMARY DOCUMENT

Filing date
14 Feb 2022
Reporting date
31 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .